Suchergebnisse - Alain Delcayre

  • Treffer 1 - 7 von 7
Treffer weiter einschränken
  1. 1
    Epstein Barr virus/complement C3d receptor is an interferon alpha receptor.

    Epstein Barr virus/complement C3d receptor is an interferon alpha receptor. von Alain Delcayre, Fernando Javier Sanhueza Salas, S. Mathur, K. Kovats, Martin Lotz, Waldemar Lernhardt

    Veröffentlicht 1991
    Volltext Volltext
    Artigo
    Zu den Favoriten
    Gespeichert in:
  2. 2
    Extracellular Vesicle–Mediated <i>In Vitro</i> Transcribed mRNA Delivery for Treatment of HER2+ Breast Cancer Xenografts in Mice by Prodrug CB1954 without General Toxicity

    Extracellular Vesicle–Mediated <i>In Vitro</i> Transcribed mRNA Delivery for Treatment of HER2+ Breast Cancer Xenografts in Mice by Prodrug CB1954 without General Toxicity von Alexis V. Forterre, Jing‐Hung Wang, Alain Delcayre, Kyuri Kim, Carol Green, Mark D. Pegram, Stefanie S. Jeffrey, A. Matin

    Veröffentlicht 2020
    Volltext Volltext
    Artigo
    Zu den Favoriten
    Gespeichert in:
  3. 3
    Targeting Tumor Antigens to Secreted Membrane Vesicles<i>In vivo</i>Induces Efficient Antitumor Immune Responses

    Targeting Tumor Antigens to Secreted Membrane Vesicles<i>In vivo</i>Induces Efficient Antitumor Immune Responses von Ingrid S. Zeelenberg, Matías Ostrowski, Sophie Krumeich, Angélique Bobrie, Carolina Jancic, Alexandre Boissonnas, Alain Delcayre, Jean‐Bernard Le Pecq, Béhazine Combadière, Sebastián Amigorena, Clotilde Théry

    Veröffentlicht 2008
    Volltext Volltext
    Artigo
    Zu den Favoriten
    Gespeichert in:
  4. 4
    Anti-HER2 scFv-Directed Extracellular Vesicle-Mediated mRNA-Based Gene Delivery Inhibits Growth of HER2-Positive Human Breast Tumor Xenografts by Prodrug Activation

    Anti-HER2 scFv-Directed Extracellular Vesicle-Mediated mRNA-Based Gene Delivery Inhibits Growth of HER2-Positive Human Breast Tumor Xenografts by Prodrug Activation von Jing‐Hung Wang, Alexis V. Forterre, Jinjing Zhao, Daniel O. Frimannsson, Alain Delcayre, Travis J. Antes, Bradley Efron, Stefanie S. Jeffrey, Mark D. Pegram, A. Matin

    Veröffentlicht 2018
    Volltext Volltext
    Artigo
    Zu den Favoriten
    Gespeichert in:
  5. 5
    Exosome Targeting of Tumor Antigens Expressed by Cancer Vaccines Can Improve Antigen Immunogenicity and Therapeutic Efficacy

    Exosome Targeting of Tumor Antigens Expressed by Cancer Vaccines Can Improve Antigen Immunogenicity and Therapeutic Efficacy von Ryan B. Rountree, Stefanie Mandl, James M. Nachtwey, Katie Dalpozzo, Lisa Do, John R. Lombardo, Peter L. Schoonmaker, Kay Brinkmann, Ulrike Dirmeier, Reiner Laus, Alain Delcayre

    Veröffentlicht 2011
    Volltext Volltext
    Artigo
    Zu den Favoriten
    Gespeichert in:
  6. 6
    A phase I study of dexosome immunotherapy in patients with advanced non-small cell lung cancer

    A phase I study of dexosome immunotherapy in patients with advanced non-small cell lung cancer von Michael A. Morse, Jennifer Garst, Takuya Osada, Shubi Khan, Amy Hobeika, Timothy M. Clay, Nancy Valente, Revati Shreeniwas, Mary Ann Sutton, Alain Delcayre, Di‐Hwei Hsu, Jean‐Bernard Le Pecq, H. Kim Lyerly

    Veröffentlicht 2005
    Volltext Volltext
    Artigo
    Zu den Favoriten
    Gespeichert in:
  7. 7
    Increasing vaccine potency through exosome antigen targeting

    Increasing vaccine potency through exosome antigen targeting von Zachary C. Hartman, Jun-Ping Wei, Oliver Glass, Hongtao Guo, Gangjun Lei, Xiaoyi Yang, Takuya Osada, Amy Hobeika, Alain Delcayre, Jean‐Bernard Le Pecq, Michael A. Morse, Timothy M. Clay, H. Kim Lyerly

    Veröffentlicht 2011
    Volltext
    Artigo
    Zu den Favoriten
    Gespeichert in:

Suchwerkzeuge: